Showing results (191-200 of 439) with videos related to
Sort By:
Pageof 44
Blood Reviews|April 12, 2025
Navigating acute myeloid leukemia towards better outcomes: Treatment pathways and challenges for patients ineligible for intensive chemotherapyRaffaele Palmieri, Anna Candoni, Francesco Di Raimondo, et al.Hematological Oncology|May 8, 2015
Lenalidomide for myelodysplastic syndromes with del(5q): how long should it last?Federico Vozella, Roberto Latagliata, Ida Carmosino, et al.Annals of Hematology|June 11, 2014
Negative prognostic value of CD34 antigen also if expressed on a small population of acute promyelocytic leukemia cellsMassimo Breccia, Maria Stefania De Propris, Caterina Stefanizzi, et al.Annals of Hematology|May 13, 2019
Ten-year outcome of chronic-phase chronic myeloid leukemia patients treated with imatinib in real lifeMatteo Molica, Gioia Colafigli, Emilia Scalzulli, et al.Leukemia & Lymphoma|October 29, 2009
Efficacy of the BEACOPP regimen in refractory and relapsed Hodgkin lymphomaElena Cavalieri, Angela Matturro, Giorgia Annechini, et al.Acta Haematologica|December 1, 2006
Late relapses in acute promyelocytic leukaemiaRoberto Latagliata, Ida Carmosino, Massimo Breccia, et al.Journal of Clinical Medicine|November 9, 2024
Does Occupational Exposure to Chemicals/Carcinogens Affect the Hematological Parameters of Workers?Giuseppe La Torre, Maria Vittoria Manai, Luca Moretti, et al.Haematologica|February 3, 2004
Clinico-biological features and outcome of acute promyelocytic leukemia patients with persistent polymerase chain reaction-detectable disease after the AIDA front-line induction and consolidation therapyMassimo Breccia, Daniela Diverio, Nélida Inés Noguera, et al.European Journal of Haematology|January 23, 2013
Rapid loss of response after withdrawal of treatment with azacitidine: a case series in patients with higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemiaMaria Teresa Voso, Massimo Breccia, Monia Lunghi, et al.International Journal of Hematology|May 13, 2022
Autologous stem cell transplantation in favorable-risk acute myeloid leukemia: single-center experience and current challengesSaveria Capria, Silvia Maria Trisolini, Daniela Diverio, et al.Pageof 44